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Summary
Recognition molecules of the immunoglobulin (Ig) super-
family control axon guidance in the developing nervous
system. Ig-like domains are among the most widely repre-
sented protein domains in the human genome, and the
number of Ig superfamily proteins is strongly correlated
with cellular complexity [1]. In Drosophila, three Round-
about (Robo) Ig superfamily receptors respond to their
common Slit ligand to regulate axon guidance at the midline:
Robo and Robo2 mediate midline repulsion, Robo2 and
Robo3 control longitudinal pathway selection, and Robo2
can promote midline crossing [2–5]. How these closely
related receptors mediate distinct guidance functions is
not understood. We report that the differential functions of
Robo2 and Robo3 are specified by their ectodomains and
do not reflect differences in cytoplasmic signaling. Func-
tional modularity of Robo2’s ectodomain facilitates multiple
guidance decisions: Ig1 and Ig3 of Robo2 confer lateral posi-
tioning activity, whereas Ig2 confers promidline crossing
activity. Robo2’s distinct functions are not dependent on
greater Slit affinity but are instead due in part to differences
in multimerization and receptor-ligand stoichiometry con-
ferred by Robo2’s Ig domains. Together, our findings
suggest that diverse responses to the Slit guidance cue
are imparted by intrinsic structural differences encoded in
the extracellular Ig domains of the Robo receptors.
Results and Discussion
Longitudinal Pathway Choice Is Dictated
by Individual Robo Receptors
In the Drosophila embryonic central nervous system (CNS),
Robo receptors are expressed in overlapping domains that
divide the longitudinal axon connectives into three broad
zones: axons occupying the medial zone express Robo, axons
in the intermediate zone express Robo and Robo3, and axons
in the most lateral zone express Robo, Robo2, and Robo3.
Loss of robo2 shifts lateral axons to intermediate positions,
whereas loss of robo3 shifts intermediate axons to medial
positions. Conversely, ectopic expression of Robo2 or
Robo3 in medial axons forces them to select more lateral path-
ways, whereas increased levels of Robo do not. The ‘‘Robo
code’’ model posits that a combinatorial code of Robo
receptor expression determines the lateral position of CNS
axons [3, 4]. To test whether a combinatorial code is neces-
sary, we assayed the ability of Robo2 and Robo3 to shift
apterous axons in embryos deficient for various combinations
of robo genes and found that removing endogenous robo or*Correspondence: gbashaw@mail.med.upenn.edurobo3 did not affect Robo2’s ability to shift apterous axons
laterally (Figure 1). Indeed, UAS-Robo2 was sufficient to direct
the apterous axons to the lateral edge of the connectives
even in robo3, robo double mutant embryos. Similarly,
removal of robo2 or robo had little or no effect on the ability
of UAS-Robo3 to redirect the apterous axons to more lateral
pathways (see Figure S1 available online). Thus, it is the indi-
vidual expression of Robo2 and Robo3 that dictates lateral
positions of CNS axons, not a combinatorial Robo code.An Unexpected Role for Robo Extracellular Domains
Robo2 and Robo3 dictate the lateral position of axons in the
Drosophila CNS, a role that is not shared by Robo (Figure S2).
What is the basis for this differential activity? All three recep-
tors have similar ectodomains with five immunoglobulin (Ig)
domains and three fibronectin (Fn) III repeats, whereas their
cytoplasmic domains are more divergent. In particular,
Robo2 and Robo3 both lack two conserved motifs (CC2 and
CC3) that mediate interactions with several downstream effec-
tors and are required for Robo’s midline repulsive function [6],
leading to the speculation that distinct Robo functions are
directed by their cytoplasmic domains [4, 7]. To determine
whether the functional difference between Robo2-Robo3 and
Robo is due to a qualitative difference in cytoplasmic sig-
naling, we assayed a set of chimeric receptors for their ability
to induce lateral shifting in the medial apterous axons.
First, the cytoplasmic domain of Robo was replaced with
that of Robo2 or Robo3 (Robo1:2 and Robo1:3). Neither of
these receptor variants was able to reposition the apterous
axons (Figure S3). In contrast, when the cytoplasmic domains
of Robo2 or Robo3 were replaced by that of Robo, the result-
ing chimeric receptors (Robo2:1 and Robo3:1) exhibited lateral
positioning activity similar to full-length Robo2 and Robo3
(Figure S3). These results reveal that the lateral positioning
activities of Robo2 and Robo3 are specified by their ectodo-
mains. Importantly, the cytoplasmic domains of Robo2 and
Robo3 are not dispensable for lateral positioning activity,
because receptors without any cytodomains are unable to
redirect the apterous axons laterally (data not shown).
Because Robo cytoplasmic domains are functionally inter-
changeable for longitudinal pathway selection, any required
intracellular events must be mediated by cytoplasmic
sequences that are common to Robo, Robo2, and Robo3.Robo2 Ig Domains Specify Lateral Positioning Activity
To dissect the structural basis underlying the differential activ-
ities of Robo receptor extracellular domains, we examined the
relative contributions of Robo2’s Ig and Fn domains by gener-
ating a more restricted set of domain swaps between Robo
and Robo2 (Figure 2). Exchanging all five Ig domains between
Robo and Robo2 completely swapped their lateral positioning
activities (Figures 2B–2E; Figure S4). These results reveal that
Robo2’s ability to position axons is specified entirely by its Ig
domains. However, the Fn repeats are not completely dispens-
able for lateral positioning activity because Robo2 variants
lacking these elements displayed reduced activity (data not
shown). Thus, when combined with Robo2’s five Ig domains,
Figure 1. Robo2 Dictates Lateral Position in the Absence of Robo
and Robo3
Stage 16–17 apGAL4::UAS-TauMycGFP embryos stained with mAb 1D4
(anti-FasII, magenta) and anti-GFP (green; labels the cell bodies and axons
of the apterous neurons). Small panels show 1D4 (top) and anti-GFP
(bottom); large panels show merged images. Anterior is up.
(A) In wild-type embryos, the apterous axons (arrowheads) select a longitu-
dinal pathway that lies directly adjacent to the medial FasII-positive axon
tract.
(B) Ectopic expression of Robo2 in the apterous neurons of wild-type
embryos causes their axons to select a longitudinal pathway farther from
the midline (arrowheads).
(C) In robo mutants, the medial FasII pathway ectopically crosses and
recrosses the midline. The apterous axons also collapse along the midline
and follow the medial FasII tract (arrowheads).
(D) Loss of endogenous robo does not affect the ability of ectopic Robo2 to
direct the apterous axons to lateral pathways (arrowheads).
(E) In robo3 mutants, the intermediate FasII tract shifts toward the midline
and joins the medial pathway. Thus, only two distinct FasII-positive bundles
(medial and lateral) are visible in these embryos. The apterous axons are
found in their wild-type position directly adjacent to the medial FasII tract
(arrowheads).
(F) Loss of endogenous robo3 does not affect the ability of ectopic Robo2 to
force the apterous axons to extreme lateral positions (arrowheads).
(G) In robo3, robodouble mutants, the intermediate FasII tract fuses with the
medial tract (because of loss of robo3), and this thick fascicle crosses the
midline (because of loss of robo). As in robo mutants, the apterous axons
follow this fascicle across the midline (arrowheads). Note that the lateral
FasII-positive tract remains in robo3, robo double mutants, confirming
that Robo2 alone is sufficient to specify the correct position of this pathway
(arrow).
(H) Ectopic Robo2 is able to direct the apterous axons to extreme lateral
positions even in the absence of both robo and robo3.
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568the Fn repeats and cytoplasmic domain of Robo can act
permissively to facilitate lateral pathway choice.
The five Ig domains of Robo2 are necessary and sufficient to
functionally distinguish it from Robo in the context of longitu-
dinal pathway choice. To subdivide the ectodomains of Robo
and Robo2 further, we targeted the presumptive Slit-binding
region (Ig1). We initially swapped Ig1 and Ig2 together,
because some evidence suggested that Ig2 could contribute
to Slit binding of human Robo receptors [8]. Robo variants
possessing the first and second Ig domains of Robo2 (Ro-
bo1R2I1+2) displayed activity comparable to full-length Robo2
(Figure 2F; Figure S4). However, the converse swap revealed
that Robo2 still retained its activity even when its Ig1+2 was
replaced with those of Robo (Robo2R1I+2) (Figure 2F; Fig-
ure S4). These results reveal a bipartite contribution to
Robo2’s lateral positioning activity from (at least) two geneti-
cally separable elements located within Ig1+2 and Ig3–5,
respectively.
We next tested whether Ig1 and Ig3 together could be
responsible for dictating the lateral positioning activity of
Robo2. Replacing Ig1 or Ig3 of Robo with those of Robo2, alone
(Robo1R2I1 and Robo1R2I3) or in combination (Robo1R2I1+3),
was sufficient to confer Robo2-equivalent activity to Robo
(Figures 2G and 2H). Importantly, replacing Ig1–3 of Robo2
with the corresponding domains of Robo eliminated its lateral
positioning activity, demonstrating that the Ig1–3 region is
both necessary and sufficient to functionally distinguish
Robo1 and Robo2 in the context of longitudinal pathway choice
(Figure 2G).
We have shown that Ig1 and Ig3 of Robo2 can independently
specify its ability to redirect medial axons to more lateral path-
ways. Further, the lateral positioning activities of chimeric
receptors containing Ig1 or Ig3 of Robo2 were indistinguish-
able in our apterous neuron assay. To determine whether
these receptors could also influence longitudinal pathway
choice in a broader context, we examined the effects of pan-
neuronal misexpression of selected chimeric receptors on
lateral positioning of FasII-positive axon pathways (Figure 3).
In wild-type embryos or elavGAL4;UAS-Robo embryos,
three major FasII-positive tracts were detectable on either
side of the midline (Figures 3A and 3D). Pan-neuronal misex-
pression of Robo2, in contrast, disrupted longitudinal pathway
formation such that the intermediate FasII pathway was
absent in nearly all segments (Figure 3B). Notably, this effect
appeared to depend solely on Ig3 of Robo2, because it was
recapitulated by UAS-Robo2R1I1+2 and UAS-Robo1R2I3, but
not by UAS-Robo1R2I1+2 or UAS-Robo2R1I1-3 (Figure 3; data
not shown). These observations draw a functional distinction
between the activities of Ig1 and Ig3 of Robo2 and suggest
that these two domains regulate longitudinal pathway choice
via distinct mechanisms.
The Lateral Positioning Activity of Robo2 Is Slit Dependent
Because the Slit-binding Ig1 contributes to Robo2’s lateral
positioning activity, it is possible that Robo2 regulates longitu-
dinal pathway selection in response to Slit. If so, then removing
slit or disrupting its interaction with Robo2 should reduce
or eliminate Robo2’s lateral positioning activity. Therefore,
we examined the effects of Robo2 misexpression in apterous
axons in a slit mutant background. In the absence of Slit, the
entire axon scaffold collapsed at the midline, and even
high levels of ectopic Robo2 could not force the apterous
axons laterally (Figures 4A and 4B). This may indicate a
direct requirement for Slit or instead reflect the inability of
Figure 2. Multiple Robo2 Ig Domains Independently Dictate Its Lateral Positioning Activity
(A and F–H) Schematic representation of domain swap constructs targeting all five Ig domains (A), the first two Ig domains (F), or the first and third Ig domains
(G and H) of Robo and Robo2. Sequence elements derived from Robo are shown in blue, whereas Robo2 elements are shown in yellow.
(B and D) Replacing all five Ig domains of Robo with those of Robo2 (Robo1R2I1-5) confers lateral positioning activity equivalent to full-length Robo2.
(C and E) Replacing all five Ig domains of Robo2 with those of Robo (Robo2R1I1-5) disrupts its lateral positioning activity. This receptor variant displays
equivalent activity to Robo1:2 and full-length Robo; even at higher expression levels, UAS-Robo2R1I1-5 can barely match the weakest of the
UAS-Robo1R2I1-5 lines.
(F) Swapping the first and second Ig domains between Robo and Robo2 results in two complementary receptors with equivalent lateral positioning activity,
similar to Robo1R2I1-5. Therefore, both Ig1+2 and Ig3–5 of Robo2 can independently confer Robo2-like lateral positioning activity in the context of an other-
wise Robo-specific receptor.
(G) Replacing the first and third Ig domains of Robo with the corresponding domains of Robo2 (Robo1R2I1+3) confers lateral positioning activity equivalent to
full-length Robo2, whereas replacing Ig1–3 of Robo2 with the corresponding region of Robo (Robo2R1I1-3) disrupts this activity.
(H) Ig1 (Robo1R2I1) or Ig3 (Robo1R2I3) of Robo2 are individually sufficient to confer Robo2-like lateral positioning activity to Robo. We are unable to formally
rule out a contribution from Robo2 Ig2 in this context, because the chimeric receptors that would allow us to do so (Robo1R2I2 and Robo2R1I1+3) were
unstable when expressed in neurons or cultured cells (data not shown). See Figures S4 and S5 for additional quantification and expression data. See Supple-
mental Experimental Procedures for method of quantifying lateral position. n denotes number of hemisegments scored for the lines shown.
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569Robo2-expressing apterous axons to move outside of the
collapsed axon scaffold.
We next asked whether Robo2 could reposition axons
without its Slit-binding region. To ensure complete disruption
of Slit binding, we deleted both the first and second Ig domains
from Robo2 and found that Robo2DIg1+2 was completely unable
to reposition the apterous axons (Figure 4C). Deleting these
two domains did not interfere with expression or localization
of Robo2 (Figure 4D). Together, these results provide evidence
that Robo2-directed lateral positioning is dependent on inter-
actions with Slit; however, we note that in addition to disrupting
Slit binding, deletion of Ig1 and Ig2 would also disrupt otherpotentially important functions of these domains. Genetic
analysis of the role of robo3 in the regulation of lateral chordo-
tonal axon arborization within the CNS also supports Slit-
dependent control of lateral position by Robo receptors [9].
Robo2’s Ability to Promote Midline Crossing Depends
on Ig2
Interestingly, pan-neuronal misexpression of Robo2 results
in phenotypes that are inconsistent with a strictly repulsive
function for Robo2 [5]. At the highest levels of overexpression,
Robo2 prevents all midline crossing. However, moderate
levels of Robo2 overexpression lead to ectopic midline
Figure 3. Differential Functions of Robo2’s Ig1, Ig2, and Ig3 Domains in
Regulating Longitudinal Pathway Formation and Midline Crossing
HA-tagged wild-type and chimeric receptors were crossed to elavGAL4,
and the embryonic central nervous system axon scaffold and major longitu-
dinal pathways were detected with anti-HRP (magenta) and anti-FasII
(green) antibodies.
Promidline crossing activity of Robo2: misexpression of any receptor
variant that includes Ig2 of Robo2 (B, Robo2; C, Robo1R2I1+2) resulted in
thickened commissures and ectopic midline crossing of FasII-positive
axons (compare to wild-type, A). This phenotype resembles a reduction
in robo function. Full-length Robo1 or chimeric receptors possessing the
cytodomain, Fn domains, or Ig1, Ig3, Ig4, or Ig5 of Robo2 did not enhance
midline crossing (D, Robo1; E, Robo2R1I1+2; F, Robo1R2I1). Graph shows
frequency of ectopic midline crossing of FasII-positive axons for two trans-
genic lines each for the variants shown in (B)–(F). Error bars indicate stan-
dard error of the mean.
Disruption of FasII pathway formation: pan-neuronal misexpression of
Robo2 disrupts the formation of the intermediate FasII pathway (B, arrow-
head with asterisk; compare to wild-type, A); the axons that normally select
this pathway apparently instead join the medial FasII tract, which becomes
thicker in elavGAL4;UAS-Robo2 embryos. Although Robo1R2I1+2 recapitu-
lates the promidline crossing activity of Robo2, it does not mimic Robo2’s
effect on FasII pathway formation (C, arrowhead). In contrast, Robo2R1I1+2
is unable to promote midline crossing in this context but does reproduce
Robo2’s disruption of the intermediate FasII pathway (E, arrowhead with
asterisk). A similar reduction of the intermediate pathway is produced by
Robo1R2I3 but not Robo2R1I1-3 (data not shown), indicating that it is due
solely to Robo2’s Ig3 domain. Ig1 of Robo2 neither promotes midline
crossing nor affects formation of the FasII longitudinal pathways (F).
Figure 4. Evidence for Slit Dependence of Lateral Positioning by Robo2
(A) In slit mutants, all axons collapse at the midline, reflecting a complete
absence of midline repulsion. The apterous axons project directly to the
midline and do not leave.
(B) High levels of Robo2 misexpression (conferred by EPRobo2) are insuffi-
cient to direct apterous axons away from the midline in the absence of Slit.
(C) A Robo2 receptor variant lacking its first and second Ig domains
(Robo2DIg1+2) is unable to alter the lateral position of the apterous axons,
even when its expression level is increased by adding a second copy of
UAS-Robo2DIg1+2 (data not shown).
(D) Robo2DIg1+2 is expressed in apterous neurons and is preferentially local-
ized to axons; therefore, the lack of activity we observed is not due to
protein instability or mislocalization.
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570crossing, suggesting that in some contexts Robo2 can pro-
mote midline crossing. Perhaps Robo2, like the divergent
Robo receptor Rig-1/Robo3 in vertebrates [10], can antago-
nize Slit-Robo repulsion.
We used our panel of chimeric receptors to map this activity
of Robo2. All of the receptor variants that contain Ig2 of Robo2
promoted midline crossing when misexpressed with elav-
GAL4, whereas those that contain regions of Robo2 apart
from Ig2 did not (Figure 3; Figures S2–S5). Thus, the promidline
crossing activity of Robo2 is conferred by Ig2. Interestingly,
rather than being excluded from the crossing portions of
axons like all other Robo receptor variants, Robo2 proteins
that promoted midline crossing were expressed strongly on
crossing axons (Figures S2–S4). This localization to crossing
axons was not shared by any of the Robo3 or Robo3-Robo1
receptors (Figures S2 and S3).
Although we cannot at present address the mechanism of
Robo2’s procrossing function, the fact that it is dependent on
Ig2 alone suggests that it is probably not due to Robo2 binding
Slit and sequestering Slit away from endogenous Robo. We
also note that this crossing activity does not correlate with
lateral positioning activity, because some variants with strong
lateral positioning activity (e.g., Robo2R1I1+2, Robo1R2I1+3,
Robo1R2I1, and Robo1R2I3) do not promote ectopic midline
crossing. It will be interesting to determine whether Robo2 in
Drosophila promotes midline crossing through inhibition of
Robo or, alternatively, whether it mediates midline attraction
in certain contexts. If, like Rig-1/Robo3, Robo2 acts as an anti-
repellent, it is likely to achieve this function through a distinct
mechanism because Rig-1/Robo3’s antirepellent function is









Ig1 Y N N N
Ig2 ? Y Y N
Ig3 Y N N Y
Ig4 N N N N
Ig5 N N N N
Summary of functional contributions from each of the five Ig domains of
Robo2. Both Ig1 and Ig3 can individually confer lateral positioning activity,
whereas Ig4 and Ig5 cannot. Ig2’s contribution to lateral positioning activity
has not been individually verified. Ig2 is the only Robo2 Ig domain that
confers antirepellant activity; Ig2-containing variants that promote ectopic
midline crossing are also detectable on commissural axons. Ig3-containing
variants disrupt intermediate FasII pathway formation when misexpressed
pan-neuronally. Lateral positioning activity is not correlated with antirepel-
lant activity.
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571specified by its cytoplasmic domain [11]. A summary of the
contributions of Robo2’s Ig domains to its different guidance
functions is presented in Table 1.
Robo2’s Lateral Positioning Activity Is Not Due
to Increased Slit Affinity
Because Robo2’s Ig domains control lateral positioning, one
possibility is that Robo2 may have a higher affinity for Slit,(C) His-tagged wild-type and chimeric Robo receptor Ig1–5 fragments were sub
ized ultraviolet absorbance at 280 nm versus elution time. The Ig1–5 fragmen
In contrast, Ig1–5 fragments of Robo2 and Robo2R1I1+2 are present nearly exclu
weight than Robo1 and Robo1R2I1+2. A large (w120 kDa) His-rich endogenous
present in all samples. The His-rich contaminant is a large multimeric complex
(peak with asterisk in top two traces). On an SDS-PAGE gel, the individual
Ig1–5 Robo fragments and are thus easily distinguishable. The presence and
SDS-PAGE (data not shown), which confirmed that virtually no Robo1 or Ro
Robo2R1I1+2 overlapped strongly with this peak.encouraging Robo2-expressing axons to seek out positions
farther down the Slit gradient. To test this possibility, we
purified the Ig domain-containing portions of the Robo and
Robo2 ectodomains and compared their affinities for the
Robo-binding domain of Slit (Slit D2) with surface plasmon
resonance (SPR). We found that Robo2 does not exhibit a
higher Slit affinity than Robo; instead, the Ig1–5 region of
Robo binds Slit D2 around 4-fold as strongly as the equivalent
region of Robo2 (apparent affinity [KD] of 235 6 165 nM for
Robo1 versus 1098 6 193 nM for Robo2) (Figure 5). Thus,
the functional distinction between Robo and Robo2 for longi-
tudinal pathway choice is not increased Slit affinity of Robo2.
Furthermore, these observations suggest that the promidline
crossing activity of Robo2 does not result from greater Slit
affinity.Differential Receptor Multimerization Partially Accounts
for the Distinct Activities of Robos
Apart from modest affinity differences, we observed a second
distinction between the Slit binding profiles of Robo and
Robo2. When tested against a constant amount of immobilized
Slit, the maximum equilibrium binding response for Robo was
approximately half of that for Robo2 (44% 6 7% maximal
binding) (Figure 5B). Thus, at equilibrium, the same amount of
Slit can bind twice as much Robo2 as Robo, suggesting a
difference in receptor-ligand stoichiometry. Size-exclusionFigure 5. Robo1 and Robo2 Ig Domains Exhibit
Distinct Multimerization and Slit Binding Pro-
perties
(A) Ig1–5 fragments of Robo1, Robo2, Ro-
bo1R2I1+2, and Robo2R1I1+2 were purified and
used for the biochemical analyses described
below. Left: protein schematics showing
domains present in wild-type and chimeric
receptor fragments. Right: Coomassie-stained
SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) gel of purified proteins, loaded at
a concentration ofw0.3 mg/ml.
(B) Surface plasmon resonance analysis indi-
cates that Ig1–5 fragments of Robo1 and Robo2
exhibit distinct Slit affinities and maximal binding
responses. Slit D2 was immobilized on a sensor
chip, and increasing concentrations of soluble
Robo fragments were flowed over the chip.
Normalized response values at equilibrium were
plotted against Robo concentration and fitted to
a one-site binding curve, from which affinity
(KD) and maximum response (Bmax) values were
derived. Robo1 Ig1–5 binds Slit D2 with an
apparent KD of 235 6 165 nM, which is around
4-fold stronger than the calculated Robo2 Ig1–5
KD of 1098 6 193 nM. In contrast, the Robo1
Bmax was only around half that of Robo2
(44% 6 7%), indicating that a given amount of
Slit D2 is capable of binding around twice as
much Robo2 as Robo. Representative curves
from a single experiment are shown; reported
values are average6 standard deviation for three
experiments.
jected to size-exclusion chromatography; results are presented as normal-
ts of Robo1 and Robo1R2I1+2 migrate as a single monomeric peak (arrow).
sively in dimeric form and migrate at a significantly larger apparent molecular
contaminant (*) was copurified from the initial nickel affinity column and is
that commonly copurifies with His-tagged proteins derived from Sf9 cells
denatured components of this complex are significantly smaller than our
distribution of receptor fragments in column fractions were analyzed by
bo1R2I1+2 was present within the contaminant peak, whereas Robo2 and
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572chromatography (SEC) confirmed that the Ig1–5 fragment of
Robo is almost exclusively monomeric in solution, whereas
Robo2 Ig1–5 appears almost exclusively as a dimer (Figure 5C).
These experiments were performed in the absence of Slit,
indicating that the observed multimerization of Robo2 is at
least partially ligand independent. However, the differences
in maximum Slit binding response in our SPR experiments
indicate that the multimerization states of Robo and Robo2
remain distinct even upon Slit binding.
To determine which region(s) of Robo2 are responsible for
dimerization and whether the observed differences in receptor
multimerization correlate with the two distinct lateral posi-
tioning activities we observed in vivo, we examined equivalent
Ig1–5 fragments derived from the chimeric receptors
Robo1R2I1+2 and Robo2R1I1+2 via SEC. These reciprocal
chimeric receptors contained distinct portions of Robo2 and
exhibited distinct large-scale effects on FasII tract formation
(Figures 3C and 3E). We found that the Robo2R1I1+2 receptor
fragment (containing Ig3–5 of Robo2) exhibited Robo2-like
Slit-independent dimerization, whereas the Robo1R2I1+2
fragment (containing Ig1+2 of Robo2) did not (Figure 5C).
Thus, ectodomain-dependent dimerization of Robo2 corre-
lates with its ability to influence large-scale longitudinal
pathway choice by FasII-positive axons and may account for
Ig3’s contribution to the lateral positioning activity of Robo2.
How do closely related axon guidance receptors, respond-
ing to a common ligand, generate diverse and, in some cases,
opposing guidance outcomes? Here we have shown that the
differential roles of the Robo receptors in directing longitudinal
pathway choice are determined by structural differences
between receptor ectodomains. In addition, we have provided
evidence that a second function of Robo2 to promote midline
crossing also depends on structural features of its ectodo-
main. We conclude that the diversification of Robo receptor
axon guidance activities is facilitated by the functional
modularity of individual receptor ectodomains. Although the
importance of guidance receptor cytoplasmic domains in
controlling guidance decisions has been known for a decade,
our results reveal that Robo receptor Ig domains play an
important part in the functional diversification of this ancient
and evolutionarily conserved guidance receptor family.
Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
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